Neurobiology of schizophrenia onset

Current Topics in Behavioral Neurosciences

Volumn 16, Issue , 2014, Pages 267-295

  Woo, Tsung Ung W ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cerebral cortex; Critical period; Dendritic spines; Extracellular matrix; GABA; Gamma band oscillation; Oxidative stress; Parvalbumin; Schizophrenia; Synaptic pruning

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABIS; GLUTAMATE DECARBOXYLASE; GLUTATHIONE; NEURONAL NITRIC OXIDE SYNTHASE; PARVALBUMIN; SYNAPTOPHYSIN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN DEVELOPMENT; COGNITIVE DEFECT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FUNCTIONAL DISEASE; GLUTAMATERGIC SYNAPSE; HUMAN; HYPOXIA; IMMUNOHISTOCHEMISTRY; INFORMATION PROCESSING; LIPID PEROXIDATION; MALNUTRITION; MICROARRAY ANALYSIS; NERVE CELL PLASTICITY; NEUROBIOLOGY; NEUROTRANSMISSION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; WORKING MEMORY; BRAIN CORTEX; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; SYNAPSE;

CEREBRAL CORTEX; EXTRACELLULAR MATRIX; HUMANS; SCHIZOPHRENIA; SYNAPSES;

EID: 84905106220     PISSN: 18663370     EISSN: 18663389     Source Type: Book Series    
DOI: 10.1007/7854_2013_243     Document Type: Article

References (226)

1. Abdul-Monim Z, Neill JC, Reynolds GP (2007) Sub-chronic psychotomimetic phencyclidine induces deficits in reversal learning and alterations in parvalbumin-immunoreactive expression in the rat. J Psychopharmacol 21:198–205
2. Akyol O, Herken H, Uz E et al (2002) The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog Neuropsychopharmacol Biol Psychiatry 26:995–1005
3. Andersen SL (2003) Tragectories of brain development: point of vulnerability or window of opportunity? Neurosci Biobehav Rev 27:3–18
4. Anderson SA, Classey JD, Conde F, Lund JS, Lewis DA (1995) Synchronous development of pyramidal neuron dendritic spines and parvalbumin-immunoreactive chandelier neuron axon terminals in layer III of monkey prefrontal cortex. Neuroscience 67:7–22
5. Arinami T, Ohtsuki T, Ishiguro H et al (2005) Genomewide high-density SNP linkage analysis of 236 Japanese families supports the existence of schizophrenia susceptibility loci on chromosomes 1p, 14q, and 20p. Am J Hum Genet 77:937–944
6. Arnsten AF, Shansky RM (2004) Adolescence: vulnerable period for stress-induced prefrontal cortical function? Introduction to part IV. Ann N Y Acad Sci 1021:143–147
7. Baba H, Suzuki T, Arai H, Emson PC (2004) Expression of nNOS and soluble guanylate cyclase in schizophrenic brain. Neuroreport 15:677–680
8. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424–C1437
9. Behrens MM, Sejnowski TJ (2009) Does schizophrenia arise from oxidative dysregulation of parvalbumin-interneurons in the developing cortex? Neuropharmacology 57:193–200
10. Behrens MM, Ali SS, Dao DN, Lucero J, Shekhtman G, Quick KL, Dugan LL (2007) Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science 318:1645–1647
11. Behrens MM, Ali SS, Dugan LL (2008) Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 28:13957–13966
12. Beinfeld MC, Connolly K (2001) Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci Lett 301:69–71
13. Benes FM (2000) Emerging principles of altered neural circuitry in schizophrenia. Brain Res Brain Res Rev 31:251–269
14. Benes FM, Berretta S (2001) GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25:1–27
15. Berardi N, Pizzorusso T, Maffei L (2000) Critical periods during sensory development. Curr Opin Neurobiol 10:138–145
16. Berk M, Copolov D, Dean O et al (2008) N-acetyl cysteine as a glutathione precursor for schizophrenia—a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 64:361–368
17. Berretta S (2012) Extracellular matrix abnormalities in schizophrenia. Neuropharmacology 62:1584–1597
18. Bi GQ, Poo MM (1998) Synaptic modifications in cultured hippocampal neurons: dependence on spike timing, synaptic strength, and postsynaptic cell type. J Neurosci 18:10464–10472
19. Bitanihirwe BK, Woo T-UW (2011) Oxidative stress in schizophrenia: an integrated approach. Neurosci Biobehav Rev 35:878–893
20. Bitanihirwe BK, Lim MP, Kelley JF, Kaneko T, Woo T-UW (2009) Glutamatergic deficits and parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia. BMC Psychiatry 9:71
21. Bossong MG, Niesink RJ (2010) Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia. Prog Neurobiol 92:370–385
22. Bourgeois JP, Goldman-Rakic PS, Rakic P (1994) Synaptogenesis in the prefrontal cortex of rhesus monkeys. Cereb Cortex 4:78–96
23. Braun I, Genius J, Grunze H, Bender A, Moller HJ, Rujescu D (2007) Alterations of hippocampal and prefrontal GABAergic interneurons in an animal model of psychosis induced by NMDA receptor antagonism. Schizophr Res 97:254–263
24. Bruckner G, Brauer K, Hartig W et al (1993) Perineuronal nets provide a polyanionic, glia-associated form of microenvironment around certain neurons in many parts of the rat brain. Glia 8:183–200
25. Buzsaki G (2006) Rhythms of the brain. Oxford University Press, New York
26. Buzsaki G, Draguhn A (2004) Neuronal oscillations in cortical networks. Science 304:1926–1929
27. Cabungcal JH, Nicolas D, Kraftsik R, Cuenod M, Do KQ, Hornung JP (2006) Glutathione deficit during development induces anomalies in the rat anterior cingulate GABAergic neurons: relevance to schizophrenia. Neurobiol Dis 22:624–637
28. Cabungcal JH, Steullet P, Kraftsik R, Cuenod M, Do KQ (2013) Early-life insults impair parvalbumin interneurons via oxidative stress: reversal by N-acetylcysteine. Biol Psychiatry 73:574–582
29. Cannon TD (1996) Abnormalities of brain structure and function in schizophrenia: implications for aetiology and pathophysiology. Ann Med 28:533–539
30. Carulli D, Rhodes KE, Brown DJ et al (2006) Composition of perineuronal nets in the adult rat cerebellum and the cellular origin of their components. J Comp Neurol 494:559–577
31. Celio MR, Blumcke I (1994) Perineuronal nets-a specialized form of extracellular matrix in the adult nervous system. Brain Res Brain Res Rev 19:128–145
32. Celio MR, Chiquet-Ehrismann R (1993) ‘Perineuronal nets’ around cortical interneurons expressing parvalbumin are rich in tenascin. Neurosci Lett 162:137–140
33. Cho RY, Konecky RO, Carter CS (2006) Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proc Natl Acad Sci USA 103:19878–19883
34. Cochran SM, Fujimura M, Morris BJ, Pratt JA (2002) Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain. Synapse 46:206–214
35. Cochran SM, Kennedy M, McKerchar CE, Steward LJ, Pratt JA, Morris BJ (2003) Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs. Neuropsychopharmacology 28:265–275
36. Cohen M, Solowij N, Carr V (2008) Cannabis, cannabinoids and schizophrenia: integration of the evidence. Aust N Z J Psychiatry 42:357–368
37. Costa E, Davis J, Grayson DR, Guidotti A, Pappas GD, Pesold C (2001) Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Neurobiol Dis 8:723–742
38. Costa E, Davis JM, Dong E, Grayson DR, Guidotti A, Tremolizzo L, Veldic M (2004) A GABAergic cortical deficit dominates schizophrenia pathophysiology. Crit Rev Neurobiol 16:1–23
39. Coyle JT (2004) The GABA-glutamate connection in schizophrenia: which is the proximate cause? Biochem Pharmacol 68:1507–1514
40. Cruz DA, Eggan SM, Lewis DA (2003) Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol 465:385–400
41. Cunningham MO, Hunt J, Middleton S et al (2006) Region-specific reduction in entorhinal gamma oscillations and parvalbumin-immunoreactive neurons in animal models of psychiatric illness. J Neurosci 26:2767–2776
42. Curley AA, Lewis DA (2012) Cortical basket cell dysfunction in schizophrenia. J Physiol 590:715–724
43. Davidsson P, Gottfries J, Bogdanovic N, Ekman R, Karlsson I, Gottfries CG, Blennow K (1999) The synaptic-vesicle-specific proteins rab3a and synaptophysin are reduced in thalamus and related cortical brain regions in schizophrenic brains. Schizophr Res 40:23–29
44. Dawson VL, Dawson TM (1996) Free radicals and neuronal cell death. Cell Death Differ 3:71–78
45. Deepa SS, Carulli D, Galtrey C et al (2006) Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans. J Biol Chem 281:17789–17800
46. Di Cristo G (2007) Development of cortical GABAergic circuits and its implications for neurodevelopmental disorders. Clin Genet 72:1–8
47. Dityatev A, Schachner M (2003) Extracellular matrix molecules and synaptic plasticity. Nat Rev Neurosci 4:456–468
48. Dityatev A, Schachner M, Sonderegger P (2010) The dual role of the extracellular matrix in synaptic plasticity and homeostasis. Nat Rev Neurosci 11:735–746
49. Do KQ, Trabesinger AH, Kirsten-Kruger M et al (2000) Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci 12:3721–3728
50. Do KQ, Cabungcal JH, Frank A, Steullet P, Cuenod M (2009) Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol 19:220–230
51. Durstewitz D, Gabriel T (2007) Dynamical basis of irregular spiking in NMDA-driven prefrontal cortex neurons. Cereb Cortex 17:894–908
52. Eastwood SL, Burnet PW, Harrison PJ (1995) Altered synaptophysin expression as a marker of synaptic pathology in schizophrenia. Neuroscience 66:309–319
53. Engel AK, Konig P, Kreiter AK, Schillen TB, Singer W (1992) Temporal coding in the visual cortex: new vistas on integration in the nervous system. Trends Neurosci 15:218–226
54. Esquenazi S, Monnerie H, Kaplan P, Le Roux P (2002) BMP-7 and excess glutamate: opposing effects on dendrite growth from cerebral cortical neurons in vitro. Exp Neurol 176:41–54
55. Fagiolini M, Fritschy JM, Low K, Mohler H, Rudolph U, Hensch TK (2004) Specific GABAA circuits for visual cortical plasticity. Science 303:1681–1683
56. Feinberg I (1982) Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17:319–334
57. Fernandez-Egea E, Bernardo M, Donner T et al (2009) Metabolic profile of antipsychotic-naive individuals with non-affective psychosis. Br J Psychiatry 194:434–438
58. Freund TF (2003) Interneuron Diversity series: Rhythm and mood in perisomatic inhibition. Trends Neurosci 26:489–495
59. Frischknecht R, Gundelfinger ED (2012) The brain’s extracellular matrix and its role in synaptic plasticity. Adv Exp Med Biol 970:153–171
60. Frischknecht R, Seidenbecher CI (2008) The crosstalk of hyaluronan-based extracellular matrix and synapses. Neuron Glia Biol 4:249–257
61. Gabbott PL, Bacon SJ (1996) Local circuit neurons in the medial prefrontal cortex (areas 24a, b, c, 25 and 32) in the monkey: I. Cell morphology and morphometrics. J Comp Neurol 364:567–608
62. Galtrey CM, Fawcett JW (2007) The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res Rev 54:1–18
63. Gao B, Fritschy JM (1994) Selective allocation of GABAA receptors containing the alpha 1 subunit to neurochemically distinct subpopulations of rat hippocampal interneurons. Eur J Neurosci 6:837–853
64. Gao B, Fritschy JM, Benke D, Mohler H (1993) Neuron-specific expression of GABAA-receptor subtypes: differential association of the alpha 1- and alpha 3-subunits with serotonergic and GABAergic neurons. Neuroscience 54:881–892
65. Garey LJ, Ong WY, Patel TS et al (1998) Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry 65:446–453
66. Garver DL, Tamas RL, Holcomb JA (2003) Elevated interleukin-6 in the cerebrospinal fluid of a previously delineated schizophrenia subtype. Neuropsychopharmacology 28:1515–1520
67. Giamanco KA, Matthews RT (2012) Deconstructing the perineuronal net: cellular contributions and molecular composition of the neuronal extracellular matrix. Neuroscience 218:367–384
68. Gianfranceschi L, Siciliano R, Walls J et al (2003) Visual cortex is rescued from the effects of dark rearing by overexpression of BDNF. Proc Natl Acad Sci U S A 100:12486–12491
69. Glahn DC, Therman S, Manninen M, Huttunen M, Kaprio J, Lonnqvist J, Cannon TD (2003) Spatial working memory as an endophenotype for schizophrenia. Biol Psychiatry 53:624–626
70. Glantz LA, Lewis DA (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity. Arch Gen Psychiatry 54:660–669
71. Glantz LA, Lewis DA (2000) Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 57:65–73
72. Glantz LA, Gilmore JH, Lieberman JA, Jarskog LF (2006) Apoptotic mechanisms and the synaptic pathology of schizophrenia. Schizophr Res 81:47–63
73. Glausier JR, Lewis DA (2011) Selective pyramidal cell reduction of GABA(A) receptor alpha1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology 36:2103–2110
74. Gogtay N, Giedd JN, Lusk L, et al. (2004) Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 101:8174–8179
75. Goldman-Rakic PS (1987) Development of cortical circuitry and cognitive function. Child Dev 58:601–622
76. Goldman-Rakic PS, Bourgeois J-P, Rakic P (1997) Synaptic substrate of cognitive development: life-span analysis of synaptogenesis in the prefrontal cortex of the nonhuman primate. In: Krasnegor NA, Lyon GR, Goldman-Rakic PS (eds) Development of the prefrontal cortex. Paul H. Brookes Publishing, Baltimore, pp 27–48
77. Gonzalez-Burgos G, Hashimoto T, Lewis DA (2010) Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 12:335–344
78. Greene R, Bergeron R, McCarley R, Coyle JT, Grunze H (2000) Short-term and long-term effects of N-methyl-D-aspartate receptor hypofunction. Arch Gen Psychiatry 57:1180–1181; author reply 1182–1183
79. Grunze HC, Rainnie DG, Hasselmo ME, Barkai E, Hearn EF, McCarley RW, Greene RW (1996) NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 16:2034–2043
80. Gundelfinger ED, Frischknecht R, Choquet D, Heine M (2010) Converting juvenile into adult plasticity: a role for the brain’s extracellular matrix. Eur J Neurosci 31:2156–2165
81. Gysin R, Kraftsik R, Sandell J et al (2007) Impaired glutathione synthesis in schizophrenia: convergent genetic and functional evidence. Proc Natl Acad Sci USA 104:16621–16626
82. Hajos M, Hoffmann WE, Kocsis B (2008) Activation of cannabinoid-1 receptors disrupts sensory gating and neuronal oscillation: relevance to schizophrenia. Biol Psychiatry 63:1075–1083
83. Hakak Y, Walker JR, Li C et al (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci USA 98:4746–4751
84. Halim ND, Weickert CS, McClintock BW, Hyde TM, Weinberger DR, Kleinman JE, Lipska BK (2003) Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development. Mol Psychiatry 8:797–810
85. Halliwell B (1984) Oxygen radicals: a commonsense look at their nature and medical importance. Med Biol 62:71–77
86. Hanover JL, Huang ZJ, Tonegawa S, Stryker MP (1999) Brain-derived neurotrophic factor overexpression induces precocious critical period in mouse visual cortex. J Neurosci 19:RC40
87. Harris KD (2005) Neural signatures of cell assembly organization. Nat Rev Neurosci 6:399–407
88. Harris KD, Csicsvari J, Hirase H, Dragoi G, Buzsaki G (2003) Organization of cell assemblies in the hippocampus. Nature 424:552–556
89. Hartig W, Derouiche A, Welt K et al (1999) Cortical neurons immunoreactive for the potassium channel Kv3.1b subunit are predominantly surrounded by perineuronal nets presumed as a buffering system for cations. Brain Res 842:15–29
90. Hashimoto T, Volk DW, Eggan SM et al (2003) Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci 23:6315–6326
91. Hashimoto T, Nguyen QL, Rotaru D et al (2009) Protracted developmental trajectories of GABA(A) receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol Psychiatry 65:1015–1023
92. Hebb DO (1949) The organization of behavior. Wiley, New York Hensch TK (2003) Controlling the critical period. Neurosci Res 47:17–22
93. Hensch TK (2005a) Critical period mechanisms in developing visual cortex. Curr Top Dev Biol 69:215–237
94. Hensch TK (2005b) Critical period plasticity in local cortical circuits. Nat Rev Neurosci 6:877–888
95. Hockfield S, Kalb RG, Zaremba S, Fryer H (1990) Expression of neural proteoglycans correlates with the acquisition of mature neuronal properties in the mammalian brain. Cold Spring Harb Symp Quant Biol 55:505–514
96. Holtzman CW, Trotman HD, Goulding SM et al (2013) Stress and neurodevelopmental processes in the emergence of psychosis. Neuroscience (in press)
97. Homayoun H, Moghaddam B (2007) NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci 27:11496–11500
98. Honer WG, Falkai P, Bayer TA et al (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb Cortex 12:349–356
99. Howard MW, Rizzuto DS, Caplan JB et al (2003) Gamma oscillations correlate with working memory load in humans. Cereb Cortex 13:1369–1374
100. Huang ZJ (2009) Activity-dependent development of inhibitory synapses and innervation pattern: role of GABA signalling and beyond. J Physiol 587:1881–1888
101. Huang ZJ, Kirkwood A, Pizzorusso T et al (1999) BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell 98:739–755
102. Huntley GW, Benson DL, Jones EG, Isackson PJ (1992) Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex. Brain Res Dev Brain Res 70:53–63
103. Huttenlocher PR (2002) Neural plasticity. Harvard University Press, Cambridge Hynes RO, Yamada KM (2012) Extracellular matrix biology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
104. Itami C, Kimura F, Nakamura S (2007) Brain-derived neurotrophic factor regulates the maturation of layer 4 fast-spiking cells after the second postnatal week in the developing barrel cortex. J Neurosci 27:2241–2252
105. Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301–1308
106. Jiang B, Huang ZJ, Morales B, Kirkwood A (2005) Maturation of GABAergic transmission and the timing of plasticity in visual cortex. Brain Res Brain Res Rev 50:126–133
107. Johansson C, Jackson DM, Svensson L (1997) Nitric oxide synthase inhibition blocks phencyclidine-induced behavioural effects on prepulse inhibition and locomotor activity in the rat. Psychopharmacology 131:167–173
108. Jones EG (1993) GABAergic neurons and their role in cortical plasticity in primates. Cereb Cortex 3:361–372
109. Kalus P, Muller TJ, Zuschratter W, Senitz D (2000) The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients. Neuroreport 11:3621–3625
110. Katagiri H, Fagiolini M, Hensch TK (2007) Optimization of somatic inhibition at critical period onset in mouse visual cortex. Neuron 53:805–812
111. Katz LC, Shatz CJ (1996) Synaptic activity and the construction of cortical circuits. Science 274:1133–1138
112. Kawaguchi Y, Kondo S (2002) Parvalbumin, somatostatin and cholecystokinin as chemical markers for specific GABAergic interneuron types in the rat frontal cortex. J Neurocytol 31:277–287
113. Kawaguchi Y, Kubota Y (1997) GABAergic cell subtypes and their synaptic connections in rat frontal cortex. Cereb Cortex 7:476–486
114. Keilhoff G, Becker A, Grecksch G, Wolf G, Bernstein HG (2004) Repeated application of ketamine to rats induces changes in the hippocampal expression of parvalbumin, neuronal nitric oxide synthase and cFOS similar to those found in human schizophrenia. Neuroscience 126:591–598
115. Keller JN, Kindy MS, Holtsberg FW et al (1998) Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J Neurosci 18:687–697
116. Keshavan MS, Anderson S, Pettegrew JW (1994) Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 28:239–265
117. Keverne EB (1999) GABA-ergic neurons and the neurobiology of schizophrenia and other psychoses. Brain Res Bull 48:467–473
118. Kinney JW, Davis CN, Tabarean I, Conti B, Bartfai T, Behrens MM (2006) A specific role for NR2A-containing NMDA receptors in the maintenance of parvalbumin and GAD67 immunoreactivity in cultured interneurons. J Neurosci 26:1604–1615
119. Kirkwood A, Lee HK, Bear MF (1995) Co-regulation of long-term potentiation and experience-dependent synaptic plasticity in visual cortex by age and experience. Nature 375:328–331
120. Klamer D, Engel JA, Svensson L (2001) The nitric oxide synthase inhibitor, L-NAME, block phencyclidine-induced disruption of prepulse inhibition in mice. Psychopharmacology 156:182–186
121. Klausberger T, Roberts JD, Somogyi P (2002) Cell type- and input-specific differences in the number and subtypes of synaptic GABA(A) receptors in the hippocampus. J Neurosci 22:2513–2521
122. Kohr G, Eckardt S, Luddens H, Monyer H, Seeburg PH (1994) NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron 12:1031–1040
123. Konig P, Engel AK, Singer W (1996) Integrator or coincidence detector? The role of the cortical neuron revisited. Trends Neurosci 19:130–137
124. Korotkova T, Fuchs EC, Ponomarenko A, von Engelhardt J, Monyer H (2010) NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 68:557–569
125. Krystal JH, Karper LP, Seibyl JP et al (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51:199–214
126. Lander C, Zhang H, Hockfield S (1998) Neurons produce a neuronal cell surface-associated chondroitin sulfate proteoglycan. J Neurosci 18:174–183
127. Lavoie S, Murray MM, Deppen P et al (2008) Glutathione precursor, N-acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33:2187–2199
128. Lehrmann E, Hyde TM, Vawter MP, Becker KG, Kleinman JE, Freed WJ (2003) The use of microarrays to characterize neuropsychiatric disorders: postmortem studies of substance abuse and schizophrenia. Curr Mol Med 3:437–446
129. Lewis DA (1995) Neural circuitry of the prefrontal cortex in schizophrenia. Arch Gen Psychiatry 52:269–273; discussion 277–268
130. Lewis DA (1997) Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 16:385–398
131. Lewis DA (2000) GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Brain Res Rev 31:270–276
132. Lewis DA (2011) The chandelier neuron in schizophrenia. Dev Neurobiol 71:118–127
133. Lewis DA, Anderson SA (1995) The functional architecture of the prefrontal cortex and schizophrenia. Psychol Med 25:887–894
134. Lewis DA, Gonzalez-Burgos G (2000) Intrinsic excitatory connections in the prefrontal cortex and the pathophysiology of schizophrenia. Brain Res Bull 52:309–317 Lewis
135. DA, Levitt P (2002) Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25:409–432
136. Lewis DA, Hashimoto T, Volk DW (2005) Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6:312–324
137. Lidow MS, Rakic P (1992) Scheduling of monoaminergic neurotransmitter receptor expression in the primate neocortex during postnatal development. Cereb Cortex 2:401–416
138. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, Grace AA (2008) Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci 31:234–242
139. Lohr JB (1991) Oxygen radicals and neuropsychiatric illness. Some speculations. Arch Gen Psychiatry 48:1097–1106
140. Maeda N, Fukazawa N, Ishii M (2010) Chondroitin sulfate proteoglycans in neural development and plasticity. Front Biosci 15:626–644
141. Magee JC, Johnston D (1997) A synaptically controlled, associative signal for Hebbian plasticity in hippocampal neurons. Science 275:209–213
142. Mahadik SP, Scheffer RE (1996) Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins Leukot Essent Fatty Acids 55:45–54
143. Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS (1998) Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biol Psychiatry 43:674–679
144. Marchbanks RM, Ryan M, Day IN, Owen M, McGuffin P, Whatley SA (2003) A mitochondrial DNA sequence variant associated with schizophrenia and oxidative stress. Schizophr Res 65:33–38
145. Mataga N, Nagai N, Hensch TK (2002) Permissive proteolytic activity for visual cortical plasticity. Proc Natl Acad Sci USA 99:7717–7721
146. Mataga N, Mizuguchi Y, Hensch TK (2004) Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron 44:1031–1041
147. Matsuzawa D, Obata T, Shirayama Y et al (2008) Negative correlation between brain glutathione level and negative symptoms in schizophrenia: a 3T 1H-MRS study. PLoS ONE 3:e1944
148. Matthews RT, Kelly GM, Zerillo CA, Gray G, Tiemeyer M, Hockfield S (2002) Aggrecan glycoforms contribute to the molecular heterogeneity of perineuronal nets. J Neurosci 22:7536–7547
149. McGlashan TH, Hoffman RE (2000) Schizophrenia as a disorder of developmentally reduced synaptic connectivity. Arch Gen Psychiatry 57:637–648
150. McGorry PD (2005) Early intervention in psychotic disorders: beyond debate to solving problems. Br J Psychiatry Suppl 48:s108–s110
151. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28:53–67
152. Miyata S, Komatsu Y, Yoshimura Y, Taya C, Kitagawa H (2012) Persistent cortical plasticity by upregulation of chondroitin 6-sulfation. Nat Neurosci 15:414–422, S411–S412
153. Morrow BA, Elsworth JD, Roth RH (2007) Repeated phencyclidine in monkeys results in loss of parvalbumin-containing axo-axonic projections in the prefrontal cortex. Psychopharmacology (Berl) 192:283–290
154. Mauney SA, Athanas KM, Pantazopoulos H, Shaskan N, Passeri E, Berretta S et al (2013) Developmental pattern of perineuronal nets in the human prefrontal cortex and their deficit in schizophrenia. Biol Psychiatry (in press)
155. Muly EC 3rd, Szigeti K, Goldman-Rakic PS (1998) D1 receptor in interneurons of macaque prefrontal cortex: distribution and subcellular localization. J Neurosci 18:10553–10565
156. Newcomer JW, Krystal JH (2001) NMDA receptor regulation of memory and behavior in humans. Hippocampus 11:529–542
157. Noack H, Possel H, Rethfeldt C, Keilhoff G, Wolf G (1999) Peroxynitrite mediated damage and lowered superoxide tolerance in primary cortical glial cultures after induction of the inducible isoform of NOS. Glia 28:13–24
158. Olney JW, Farber NB (1995) Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52:998–1007
159. Olney JW, Newcomer JW, Farber NB (1999) NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 33:523–533
160. Ozyurt B, Ozyurt H, Akpolat N, Erdogan H, Sarsilmaz M (2007) Oxidative stress in prefrontal cortex of rat exposed to MK-801 and protective effects of CAPE. Prog Neuropsychophar-macol Biol Psychiatry 31:832–838
161. Pantazopoulos H, Woo T-UW, Lim MP, Lange N, Berretta S (2010) Extracellular matrix-glial abnormalities in the amygdala and entorhinal cortex of subjects diagnosed with schizophrenia. Arch Gen Psychiatry 67:155–166
162. Park S, Holzman PS (1992) Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975–982
163. Pasternak O, Westin CF, Bouix S et al (2012) Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset. J Neurosci 32:17365–17372
164. Pierri JN, Chaudry AS, Woo TU, Lewis DA (1999) Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 156:1709–1719
165. Pierri JN, Volk CL, Auh S, Sampson A, Lewis DA (2001) Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. Arch Gen Psychiatry 58:466–473
166. Pietersen CY, Lim MP, Woo T-UW (2009) Obtaining high quality RNA from single cell populations in human postmortem brain tissue. J Vis Exp 30:e1444
167. Pietersen CY, Lim MP, Macey L, Woo T-UW, Sonntag KC (2011) Neuronal type-specific gene expression profiling and laser-capture microdissection. Methods Mol Biol 755:327–343
168. Pizzorusso T, Medini P, Berardi N, Chierzi S, Fawcett JW, Maffei L (2002) Reactivation of ocular dominance plasticity in the adult visual cortex. Science 298:1248–1251
169. Pongrac J, Middleton FA, Lewis DA, Levitt P, Mirnics K (2002) Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders. Neurochem Res 27:1049–1063
170. Prabakaran S, Swatton JE, Ryan MM et al (2004) Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 9: 643:684–697.
171. Pulver AE (2000) Search for schizophrenia susceptibility genes. Biol Psychiatry 47:221–230 Rauch U (2004) Extracellular matrix components associated with remodeling processes in brain. Cell Mol Life Sci 61:2031–2045
172. Reddy RD, Yao JK (1996) Free radical pathology in schizophrenia: a review. Prostaglandins Leukot Essent Fatty Acids 55:33–43
173. Reynolds GP, Abdul-Monim Z, Neill JC, Zhang ZJ (2004) Calcium binding protein markers of GABA deficits in schizophrenia–postmortem studies and animal models. Neurotox Res 6:57–61
174. Rosenberg DR, Lewis DA (1995) Postnatal maturation of the dopaminergic innervation of monkey prefrontal and motor cortices: a tyrosine hydroxylase immunohistochemical analysis. J Comp Neurol 358:383–400
175. Roux F, Wibral M, Mohr HM, Singer W, Uhlhaas PJ (2012) Gamma-band activity in human prefrontal cortex codes for the number of relevant items maintained in working memory. J Neurosci 32:12411–12420
176. Rujescu D, Bender A, Keck M et al (2006) A pharmacological model for psychosis based on N-methyl-D-aspartate receptor hypofunction: molecular, cellular, functional and behavioral abnormalities. Biol Psychiatry 59:721–729
177. Salinas E, Sejnowski TJ (2001) Correlated neuronal activity and the flow of neural information. Nat Rev Neurosci 2:539–550
178. Sawada K, Young CE, Barr AM et al (2002) Altered immunoreactivity of complexin protein in prefrontal cortex in severe mental illness. Mol Psychiatry 7:484–492
179. Schmitt A, Bertsch T, Tost H, Bergmann A, Henning U, Klimke A, Falkai P (2005) Increased serum interleukin-1beta and interleukin-6 in elderly, chronic schizophrenic patients on stable antipsychotic medication. Neuropsychiatr Dis Treat 1:171–177
180. Selemon LD, Goldman-Rakic PS (1999) The reduced neuropil hypothesis: a circuit based model of schizophrenia. Biol Psychiatry 45:17–25
181. Semple DM, McIntosh AM, Lawrie SM (2005) Cannabis as a risk factor for psychosis: systematic review. J Psychopharmacol 19:187–194
182. Sesack SR, Hawrylak VA, Melchitzky DS, Lewis DA (1998) Dopamine innervation of a subclass of local circuit neurons in monkey prefrontal cortex: ultrastructural analysis of tyrosine hydroxylase and parvalbumin immunoreactive structures. Cereb Cortex 8:614–622
183. Shaw P, Kabani NJ, Lerch JP et al (2008) Neurodevelopmental Trajectories of the Human Cerebral Cortex. J Neurosci 28:3586–3594
184. Siekmeier PJ, Hoffman RE (2002) Enhanced semantic priming in schizophrenia: a computer model based on excessive pruning of local connections in association cortex. Br J Psychiatry 180:345–350
185. Siekmeier PJ, Woo TUW (2012) Computational modelling of prefrontal cortex neuropathology in schizophrenia. Soc Neurosci Abs 38 Smythies JR (1997) Oxidative reactions and schizophrenia: a review-discussion. Schizophr Res 24:357–364
186. Soltesz I (2005) Diversity in the neuronal machine. Oxford University Press, New
187. York Sowell ER, Thompson PM, Tessner KD, Toga AW (2001) Mapping continued brain growth and gray matter density reduction in dorsal frontal cortex: inverse relationships during postadolescent brain maturation. J Neurosci 21:8819–8829
188. Spencer KM, Nestor PG, Niznikiewicz MA, Salisbury DF, Shenton ME, McCarley RW (2003) Abnormal neural synchrony in schizophrenia. J Neurosci 23:7407–7411
189. Steullet P, Neijt HC, Cuenod M, Do KQ (2006) Synaptic plasticity impairment and hypofunction of NMDA receptors induced by glutathione deficit: relevance to schizophrenia. Neuroscience 137:807–819
190. Sugiyama S, Prochiantz A, Hensch TK (2009) From brain formation to plasticity: insights on Otx2 homeoprotein. Dev Growth Differ 51:369–377
191. Tallon-Baudry C, Bertrand O (1999) Oscillatory gamma activity in humans and its role in object representation. Trends Cogn Sci 3:151–162
192. Tosic M, Ott J, Barral S et al (2006) Schizophrenia and oxidative stress: glutamate cysteine ligase modifier as a susceptibility gene. Am J Hum Genet 79:586–592
193. Trabesinger AH, Weber OM, Duc CO, Boesiger P (1999) Detection of glutathione in the human brain in vivo by means of double quantum coherence filtering. Magn Reson Med 42:283–289
194. Traub RD, Whittington MA (2010) Cortical oscillations in health and disease. Oxford University Press, New York
195. Tropea D, Kreiman G, Lyckman A, Mukherjee S, Yu H, Horng S, Sur M (2006) Gene expression changes and molecular pathways mediating activity-dependent plasticity in visual cortex. Nat Neurosci 9:660–668
196. Uhlhaas PJ, Singer W (2010) Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11:100–113
197. Uhlhaas PJ, Roux F, Singer W, Haenschel C, Sireteanu R, Rodriguez E (2009) The development of neural synchrony reflects late maturation and restructuring of functional networks in humans. Proc Natl Acad Sci USA 106:9866–9871
198. Uhlhaas PJ, Roux F, Rodriguez E, Rotarska-Jagiela A, Singer W (2010) Neural synchrony and the development of cortical networks. Trends Cogn Sci 14:72–80
199. Vawter MP, Barrett T, Cheadle C et al (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res Bull 55:641–650
200. Vierling-Claassen D, Siekmeier P, Stufflebeam S, Kopell N (2008) Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment. J Neurophysiol 99:2656–2671
201. Volk DW, Lewis DA (2010) Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci 4:485–508
202. Volk DW, Pierri JN, Fritschy JM, Auh S, Sampson AR, Lewis DA (2002) Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex 12:1063–1070
203. Wang XJ (1999) Synaptic basis of cortical persistent activity: the importance of NMDA receptors to working memory. J Neurosci 19:9587–9603
204. Wang XJ (2001) Synaptic reverberation underlying mnemonic persistent activity. Trends Neurosci 24:455–463
205. Wang XJ (2002) Probabilistic decision making by slow reverberation in cortical circuits. Neuron 36:955–968
206. Wang HX, Gao WJ (2009) Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 34:2028–2040
207. Wang XJ, Tegner J, Constantinidis C, Goldman-Rakic PS (2004) Division of labor among distinct subtypes of inhibitory neurons in a cortical microcircuit of working memory. Proc Natl Acad Sci USA 101:1368–1373
208. Webster MJ, Weickert CS, Herman MM, Kleinman JE (2002) BDNF mRNA expression during postnatal development, maturation and aging of the human prefrontal cortex. Brain Res Dev Brain Res 139:139–150
209. Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660–669
210. Wespatat V, Tennigkeit F, Singer W (2004) Phase sensitivity of synaptic modifications in oscillating cells of rat visual cortex. J Neurosci 24:9067–9075
211. Williams GV, Castner SA (2006) Under the curve: critical issues for elucidating D1 receptor function in working memory. Neuroscience 139:263–276
212. Wlodarczyk J, Mukhina I, Kaczmarek L, Dityatev A (2011) Extracellular matrix molecules, their receptors, and secreted proteases in synaptic plasticity. Dev Neurobiol 71:1040–1053
213. Woo TUW, Crowell AL (2005) Targeting synapses and myelin in the prevention of schizophrenia. Schizophr Res 73:193–207
214. Woo TUW, Pucak ML, Kye CH, Matus CV, Lewis DA (1997) Peripubertal refinement of the intrinsic and associational circuitry in monkey prefrontal cortex. Neuroscience 80:1149–1158
215. Woo TUW, Whitehead RE, Melchitzky DS, Lewis DA (1998) A subclass of prefrontal gamma-aminobutyric acid axon terminals are selectively altered in schizophrenia. Proc Natl Acad Sci USA 95:5341–5346
216. Woo TUW, Walsh JP, Benes FM (2004) Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry 61:649–657
217. Woo TUW, Kim AM, Viscidi E (2008) Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophrenia. Brain Res 1218:267–277
218. Woo TUW, Zimmett SV, Wojcik J, Canuso C, Green AI (2009) Treatment of schizophrenia. In: Schatzberg AF, Nemeroff CB (eds) Textbook of psychopharmacology. American Psychiatric Press.
219. Washington, DC Woo TUW, Spencer K, McCarley RW (2010) Gamma oscillation deficits and the onset and early progression of schizophrenia. Harv Rev Psychiatry 18:173–189
220. Yamaguchi Y (2000) Lecticans: organizers of the brain extracellular matrix. Cell Mol Life Sci 57:276–289
221. Yanik M, Vural H, Kocyigit A et al (2003) Is the arginine-nitric oxide pathway involved in the pathogenesis of schizophrenia? Neuropsychobiology 47:61–65
222. Yao JK, Reddy RD, van Kammen DP (2001) Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287–310
223. Yao JK, Leonard S, Reddy RD (2004) Increased nitric oxide radicals in postmortem brain from patients with schizophrenia. Schizophr Bull 30:923–934
224. Zhang XY, Zhou DF, Zhang PY, Wu GY, Cao LY, Shen YC (2002) Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology. Schizophr Res 57:247–258
225. Zoroglu SS, Herken H, Yurekli M et al (2002) The possible pathophysiological role of plasma nitric oxide and adrenomedullin in schizophrenia. J Psychiatr Res 36:309–315
226. Zuo DY, Wu YL, Yao WX, Cao Y, Wu CF, Tanaka M (2007) Effect of MK-801 and ketamine on hydroxyl radical generation in the posterior cingulate and retrosplenial cortex of free-moving mice, as determined by in vivo microdialysis. Pharmacol Biochem Behav 86:1–7